MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Top Cited Papers
Open Access
- 19 November 2015
- journal article
- Published by American Society of Hematology in Blood
- Vol. 126 (21), 2355-2361
- https://doi.org/10.1182/blood-2015-08-667063
Abstract
Key Points. Over 30% of patients with unexplained cytopenias who do not meet diagnostic criteria for MDS carry MDS-associated somatic mutations.Clonal cytopeniKeywords
This publication has 37 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)Blood, 2012
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- Detectable clonal mosaicism from birth to old age and its relationship to cancerNature Genetics, 2012
- Detectable clonal mosaicism and its relationship to aging and cancerNature Genetics, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- TET2andDNMT3AMutations in Human T-Cell LymphomaNew England Journal of Medicine, 2012
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsBlood, 2011
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsNew England Journal of Medicine, 2011
- Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patientsAnnals of Oncology, 2010